Table 3.
Proportions with seroconversion and seroprotection after vaccination among participants with CD4 cell counts > 200 cells/μL (n = 157) and CD4 cell counts > 500 cells/μL (n = 78).
| Participants with CD4 > 200 cells/μL (n = 78) | Nonobese (BMI < 30 kg/m2) (n = 110) |
Obese (BMI ≥ 30 kg/m2) (n = 47) |
p value |
|---|---|---|---|
| Seroconversion, % (95% CI) | |||
| H1N1 | 70 (61–79) | 62 (47–76) | 0.31 |
| H3N2 | 79 (71–87) | 81 (69–92) | 0.80 |
| Influenza B | 45 (36–55) | 49 (34–64) | 0.69 |
| Seroprotection, % (95% CI) | |||
| H1N1 | 94 (89–98) | 89 (80–98) | 0.36 |
| H3N2 | 98 (96–100) | 98 (94–100) | 0.90 |
| Influenza B | 92 (87–97) | 85 (74–96) | 0.20 |
|
| |||
| Participants with CD4 > 500 cells/μL (n = 78) | Nonobese (BMI < 30 kg/m2) (n = 54) |
Obese (BMI ≥ 30 kg/m2) (n = 24) |
p value |
|
| |||
| Seroconversion, % (95% CI) | |||
| H1N1 | 68 (56–81) | 75 (56–94) | 0.56 |
| H3N2 | 72 (60–84) | 79 (62–97) | 0.52 |
| Influenza B | 35 (22–48) | 38 (17–58) | 0.84 |
| Seroprotection, % (95% CI) | |||
| H1N1 | 93 (85–100) | 96 (87–100) | 0.59 |
| H3N2 | 98 (94–100) | 100 (100–100) | 0.50 |
| Influenza B | 94 (88–100) | 92 (80–100) | 0.64 |
BMI: body mass index; CI: confidence interval.